- OptumRx will pay $20 million to resolve claims the company violated the Controlled Substances Act by improperly filling certain opioid prescriptions, the Department of Justice recently announced. The agency claims OptumRx did not fill prescriptions correctly for “trinity prescriptions” like benzodiazepines and other muscle relaxants from April 2013 to April 2015. These prescriptions, which are addictive, may not have been “intended for legitimate medical use” and carry “significant risk of harm,” according to a news release. Optum has since closed its mail order pharmacy in Carlsbad, California, the site location where improper prescriptions were filled. The company said it has beefed up its protocols to limit the number of improperly filled prescriptions and has implemented a stronger drug utilization review. (Article here)
July 16, 2024
Opioid/Substance Use Disorders | Tea Leaves